Kazufumi Honda

Years Active: 2019-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Tomoaki Toyoda, Nami Miura, Shingo Kato, Takeshi Masuda, Ryuji Ohashi, Akira Matsushita, Fumio Matsuda, Sumio Ohtsuki, Akira Katakura, Kazufumi Honda
Identification of TPI1 As a potential therapeutic target in pancreatic cancer with dependency of TP53 mutation using multi-omics analysis. Cancer science (2024)
Kazuki Kawamura, Kosuke Miyai, Kimiya Sato, Susumu Matsukuma, Kazufumi Honda, Keiichi Ito, Hitoshi Tsuda
Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma. Cancer science (2023)
Rintaro Noro, Kazufumi Honda, Kengo Nagashima, Noriko Motoi, Shinobu Kunugi, Jun Matsubayashi, Susumu Takeuchi, Hideaki Shiraishi, Tetsuya Okano, Ayumi Kashiro, Xue Meng, Yukihiro Yoshida, Shunichi Watanabe, Jitsuo Usuda, Tatsuya Inoue, Huang Wilber, Norihiko Ikeda, Masahiro Seike, Akihiko Gemma, Kaoru Kubota
ACTN4 gene amplification is a predictive biomarker for adjuvant chemotherapy with UFT in stage I lung adenocarcinomas. Cancer science (2021)
Kaoru Onidani, Hirokazu Shoji, Takahiko Kakizaki, Seiichi Yoshimoto, Shinobu Okaya, Nami Miura, Shoichi Sekikawa, Koh Furuta, Chwee Teck Lim, Takahiko Shibahara, Narikazu Boku, Ken Kato, Kazufumi Honda
Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA. Cancer science 110 (8) (2019)

Kazufumi Honda.css-eqlu8i{font-size:small;padding-left:4px;}